These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24924549)

  • 1. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.
    Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
    AJNR Am J Neuroradiol; 2015 Feb; 36(2):236-44. PubMed ID: 24924549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.
    Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
    AJNR Am J Neuroradiol; 2015 Feb; 36(2):229-35. PubMed ID: 24904053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.
    Subramaniam RM; Frey KA; Hunt CH; Mercier GA; Solnes LB; Colletti PM; Lu Y; Savir-Baruch B; Williams HT
    Clin Nucl Med; 2017 Nov; 42(11):847-852. PubMed ID: 28922189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia.
    Ishizawa K; Fujita Y; Nagashima K; Nakamura T; Shibata M; Kasahara H; Makioka K; Taketomi-Takahashi A; Hirasawa H; Higuchi T; Tsushima Y; Ikeda Y
    J Neurol Sci; 2023 Aug; 451():120713. PubMed ID: 37441875
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dopamine transporter imaging in routine clinical practice.
    Marshall V; Grosset D
    Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Challenges in the differential diagnoses of parkinsonism].
    Bech S; Haugbøl S; Winge K
    Ugeskr Laeger; 2017 Aug; 179(33):. PubMed ID: 28869013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration.
    Mark MH
    Neurol Clin; 2001 Aug; 19(3):607-27, vi. PubMed ID: 11532646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of DAT-SPECT in movement disorders.
    Kägi G; Bhatia KP; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):5-12. PubMed ID: 20019219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal Familial Insomnia Initially Developing Parkinsonism Mimicking Dementia with Lewy Bodies.
    Fukuoka T; Nakazato Y; Yamamoto M; Miyake A; Mitsufuji T; Yamamoto T
    Intern Med; 2018 Sep; 57(18):2719-2722. PubMed ID: 29709939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
    Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
    Nicastro N; Burkhard PR; Garibotto V
    J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility variants in parkinsonism.
    Soto-Ortolaza AI; Ross OA
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S7-11. PubMed ID: 26414118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopaminergic treatment and parkinsonian syndromes].
    Ghawche F; Durif F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S83-6. PubMed ID: 12773892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update.
    Tatsch K; Poepperl G
    J Nucl Med; 2013 Aug; 54(8):1331-8. PubMed ID: 23864718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing and treating atypical Parkinson disorders.
    Armstrong MJ; McFarland N
    Handb Clin Neurol; 2019; 167():301-320. PubMed ID: 31753139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
    Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
    Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.